Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ana Vega

Showing results (91-100 of 216) with videos related to

Pageof 22
Sort By:
The Journal of Molecular Diagnostics : JMD|October 21, 2023
A New Set of in Silico Tools to Support the Interpretation of ATM Missense Variants Using Graphical AnalysisLuz-Marina Porras, Natàlia Padilla, Alejandro Moles-Fernández, et al.
Physica Medica : PM : an International Journal Devoted to the Applications of Physics to Medicine and Biology : Official Journal of the Italian Association of Biomedical Physics (AIFB)|October 10, 2025
Sensitivity analysis of dose-response model parameters for the bladder in prostate cancer radiotherapyTanuj Puri, Tiziana Rancati, Petra Seibold, et al.
Breast Cancer Research and Treatment|July 20, 2011
Characterization of BRCA1 and BRCA2 splicing variants: a collaborative report by ENIGMA consortium membersMads Thomassen, Ana Blanco, Marco Montagna, et al.
International Journal of Cancer|October 17, 2013
About 1% of the breast and ovarian Spanish families testing negative for BRCA1 and BRCA2 are carriers of RAD51D pathogenic variantsSara Gutiérrez-Enríquez, Sandra Bonache, Gorka Ruíz de Garibay, et al.
Nature Genetics|July 1, 2014
A three-stage genome-wide association study identifies a susceptibility locus for late radiotherapy toxicity at 2q24.1Laura Fachal, Antonio Gómez-Caamaño, Gillian C Barnett, et al.
Antimicrobial Agents and Chemotherapy|November 7, 2025
Effectiveness of imipenem-relebactam for multidrug-resistant <i>Pseudomonas aeruginosa</i> in pneumonia and bloodstream infections in the United States (MIRAGE)Walaiporn Wangchinda, Janet Y Wu, Lilian M Abbo, et al.
International Journal of Cancer|June 2, 2004
The variant E233G of the RAD51D gene could be a low-penetrance allele in high-risk breast cancer families without BRCA1/2 mutationsRaquel Rodríguez-López, Ana Osorio, Gloria Ribas, et al.
Plos One|August 13, 2013
Analysis of PALB2 gene in BRCA1/BRCA2 negative Spanish hereditary breast/ovarian cancer families with pancreatic cancer casesAna Blanco, Miguel de la Hoya, Ana Osorio, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|June 27, 2026
Associations between body composition and radiotherapy-related side-effects and health-related quality of life in patients with prostate or lung cancer: sub-analysis of the REQUITE trialAlexander J Vickers, Donal M McSweeney, Ananya Choudhury, et al.
Orphanet Journal of Rare Diseases|July 26, 2018
Improving the diagnosis of cobalamin and related defects by genomic analysis, plus functional and structural assessment of novel variantsSandra Brasil, Fátima Leal, Ana Vega, et al.
Pageof 22

Showing results (91-100 of 216) with videos related to

Sort By:
Pageof 22
The Journal of Molecular Diagnostics : JMD|October 21, 2023
A New Set of in Silico Tools to Support the Interpretation of ATM Missense Variants Using Graphical AnalysisLuz-Marina Porras, Natàlia Padilla, Alejandro Moles-Fernández, et al.
Physica Medica : PM : an International Journal Devoted to the Applications of Physics to Medicine and Biology : Official Journal of the Italian Association of Biomedical Physics (AIFB)|October 10, 2025
Sensitivity analysis of dose-response model parameters for the bladder in prostate cancer radiotherapyTanuj Puri, Tiziana Rancati, Petra Seibold, et al.
Breast Cancer Research and Treatment|July 20, 2011
Characterization of BRCA1 and BRCA2 splicing variants: a collaborative report by ENIGMA consortium membersMads Thomassen, Ana Blanco, Marco Montagna, et al.
International Journal of Cancer|October 17, 2013
About 1% of the breast and ovarian Spanish families testing negative for BRCA1 and BRCA2 are carriers of RAD51D pathogenic variantsSara Gutiérrez-Enríquez, Sandra Bonache, Gorka Ruíz de Garibay, et al.
Nature Genetics|July 1, 2014
A three-stage genome-wide association study identifies a susceptibility locus for late radiotherapy toxicity at 2q24.1Laura Fachal, Antonio Gómez-Caamaño, Gillian C Barnett, et al.
Antimicrobial Agents and Chemotherapy|November 7, 2025
Effectiveness of imipenem-relebactam for multidrug-resistant <i>Pseudomonas aeruginosa</i> in pneumonia and bloodstream infections in the United States (MIRAGE)Walaiporn Wangchinda, Janet Y Wu, Lilian M Abbo, et al.
International Journal of Cancer|June 2, 2004
The variant E233G of the RAD51D gene could be a low-penetrance allele in high-risk breast cancer families without BRCA1/2 mutationsRaquel Rodríguez-López, Ana Osorio, Gloria Ribas, et al.
Plos One|August 13, 2013
Analysis of PALB2 gene in BRCA1/BRCA2 negative Spanish hereditary breast/ovarian cancer families with pancreatic cancer casesAna Blanco, Miguel de la Hoya, Ana Osorio, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|June 27, 2026
Associations between body composition and radiotherapy-related side-effects and health-related quality of life in patients with prostate or lung cancer: sub-analysis of the REQUITE trialAlexander J Vickers, Donal M McSweeney, Ananya Choudhury, et al.
Orphanet Journal of Rare Diseases|July 26, 2018
Improving the diagnosis of cobalamin and related defects by genomic analysis, plus functional and structural assessment of novel variantsSandra Brasil, Fátima Leal, Ana Vega, et al.
Pageof 22